Questions? +1 (202) 335-3939 Login
Trusted News Since 1995
A service for pharmaceutical industry professionals · Friday, March 29, 2024 · 699,729,865 Articles · 3+ Million Readers

Injection Types Offered by Orthopedic Surgeons and How They Can Help

Injections for Arthritis Treatment

Injections for Arthritis Treatment

patient with osteoarthritis discussing treatment options with his physician

patient with osteoarthritis discussing treatment options with her physician

BEND, OR, UNITED STATES, February 9, 2021 /EINPresswire.com/ -- Chronic conditions, such as degenerative arthritis, can often be managed with intermittent injections. Depending on the condition and underlying pathology, many patients can maintain a pain-free lifestyle for several years by only receiving injections every three to four months. If a physician or physician assistant recommends an injection to help modify symptoms, improve recovery, or manage a long-term condition, the patient should be aware of both the potential benefits and limited risk factors associated with the various types of injections.

Corticosteroid injections are used to help reduce inflammation. For years studies have proven them to be beneficial for medium to short term use. These injections are common for conditions such as osteoarthritis, gout, pseudogout, and tendinitis. They are generally approved by most insurances and usually do not require pre-authorization. Corticosteroid injections are usually very well tolerated and can be done with little or no discomfort. The most common side-effects include pain or swelling at the injection site, facial flushing or redness, and a transient elevation in blood sugar.

Hyaluronic acid, or, gel injections, have been approved by the FDA for use in the management of arthritis of the knee. Gel injections have been shown in several studies to reduce pain and inflammation associated with osteoarthritis of the knee for 6-12 months. Hyaluronic Acid injections may allow some patients to remain active and delay knee replacement. Unfortunately, these injections are often not covered by insurance and must be pre-authorized. Side effects of gel injections may include pain and swelling at the injection site.

Platelet Rich Plasma (PRP) injections are derived from a patient’s blood. Blood is taken from a patient and spun in a centrifuge to obtain a layer that consists of platelet-rich plasma with or without a high concentration of white blood cells. Think of it like an injection that is trying to help the body heal itself. By injecting activated platelets into diseased tissue, the hope is that it would induce a healing response. PRP has shown clinical promise in studies for chronic tendonitis (examples include tennis and golfer’s elbow, hamstring, or achilles tendonitis). PRP has little to no side effect risk, although pain during and after the procedure for a short term is common. There is no clear data on the number of treatments required to maximize the effect of PRP, and it is still considered to be experimental, and thus is not covered by private insurance or Medicare. The Center attempts to limit the expense to patients, and if a patient wishes to have a PRP injection, our scheduling or insurance authorization staff will contact you directly to review the scheduling and cost of the procedure.

Stem cell injections are best thought of as an immature cell that has not yet developed to become a very specific cell. As of 2021, the data on stem cells is mixed, at best, for the treatment of arthritis. Some treatments have a significant risk of infection, specifically if the source of the stem cells is from outside of the patient. The injections are costly and generally, insurance companies do not cover the treatment. Stem cell treatment for arthritis is not standardized and is currently under significant review and investigation by the FDA. The only true FDA approved stem cell products for use in the USA are derived from umbilical cord blood and are approved for very limited use. Before considering receiving any stem cell therapy, we recommend reviewing the FDA website. Ask if your treatment provider has directly approved or reviewed the specific treatment or protocol or if it is a part of an Investigational Drug Application (IND) plan, which is allowed by the FDA. Orthopedic providers at The Center for Orthopedic and Neurosurgical Care and Research in Bend, Oregon, continue to review the latest studies for the safety and efficacy of these treatments and continue to remain optimistic that someday we will have a viable stem cell option for patients.

Jenny King
The Center Orthopedic & Neurosurgical Care & Research
+1 541-382-3344
email us here

Nonsurgical Treatment of Osteoarthritis

Powered by EIN Presswire


EIN Presswire does not exercise editorial control over third-party content provided, uploaded, published, or distributed by users of EIN Presswire. We are a distributor, not a publisher, of 3rd party content. Such content may contain the views, opinions, statements, offers, and other material of the respective users, suppliers, participants, or authors.

Submit your press release